Abstract
Cre-mediated excision of exon 11 of the breast-tumour suppressor gene Brca1 in mouse mammary epithelial cells causes increased apoptosis and abnormal ductal development. Mammary tumour formation occurs after long latency and is associated with genetic instability characterized by aneuploidy, chromosomal rearrangements or alteration of Trp53 (encoding p53) transcription. To directly test the role of p53 in Brca1-associated tumorigenesis, we introduced a Trp53-null allele into mice with mammary epithelium-specific inactivation of Brca1. The loss of p53 accelerated the formation of mammary tumours in these females. Our results demonstrate that disruption of Brca1 causes genetic instability and triggers further alterations, including the inactivation of p53, that lead to tumour formation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alberg, A.J. & Helzlsouer, K.J. Epidemiology, prevention, and early detection of breast cancer. Curr. Opin. Oncol. 9, 505–511 (1997).
Hill, A.D., Doyle, J.M., McDermott, E.W. & O'Higgins, N.J. Hereditary breast cancer. Br. J. Surg. 84, 1334–1339 (1997).
Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66– 71 (1994).
Casey, G. The BRCA1 and BRCA2 breast cancer genes. Curr. Opin. Oncol. 9, 88–93 (1997).
Chen, Y. et al. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56, 3168–3172 (1996).
Cui, J.Q., Wang, H., Reddy, E.S. & Rao, V.N. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b. Oncol. Rep. 5, 585–589 (1998).
Thakur, S. et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17, 444–452 (1997).
Wilson, C.A. et al. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-δ11b. Oncogene 14, 1–16 (1997 ).
Bennett, L.M. et al. Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11. Genomics 29, 576 –581 (1995).
Muris, D.F. et al. Cloning the RAD51 homologue of Schizosaccharomyces pombe. Nucleic Acids Res. 21, 4586– 4591 (1993).
Shinohara, A., Ogawa, H. & Ogawa, T. Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 69, 457–470 (1992).
Shinohara, A. et al. Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nature Genet. 4, 239–243 (1993).
Scully, R. et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265–275 (1997).
Chen, C.F. et al. The nuclear localization sequences of the BRCA1 protein interact with the importin-α subunit of the nuclear transport signal receptor. J. Biol. Chem. 271, 32863– 32868 (1996).
Zhang, H. et al. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16, 1713– 1721 (1998).
Ouchi, T., Monteiro, A.N., August, A., Aaronson, S.A. & Hanafusa, H. BRCA1 regulates p53-dependent gene expression. Proc. Natl Acad. Sci. USA 95, 2302–2306 (1998).
Marquis, S.T. et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nature Genet. 11, 17–26 ( 1995).
Lane, T.F. et al. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9, 2712–2722 ( 1995).
Hakem, R. et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009 –1023 (1996).
Liu, C.Y., Flesken-Nikitin, A., Li, S., Zeng, Y. & Lee, W.H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10, 1835– 1843 (1996).
Gowen, L.C., Johnson, B.L., Latour, A.M., Sulik, K.K. & Koller, B.H. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nature Genet. 12, 191–194 (1996).
Shen, S.X. et al. A targeted disruption of the murine Brca1 gene causes γ-radiation hypersensitivity and genetic instability. Oncogene 17, 3115–3124 (1998).
Ludwig, T., Chapman, D.L., Papaioannou, V.E. & Efstratiadis, A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11, 1226– 1241 (1997).
Sauer, B. Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381–392 ( 1998).
Wagner, K.U. et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25, 4323–4330 (1997).
Hennighausen, L. & Robinson, G.W. Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 12, 449–455 (1998).
Rotter, V., Wolf, D., Pravtcheva, D. & Ruddle, F.H. Chromosomal assignment of the murine gene encoding the transformation-related protein p53. Mol. Cell. Biol. 4, 383–385 (1984).
Schrock, E. et al. The murine homolog of the human breast and ovarian cancer susceptibility gene Brca1 maps to mouse chromosome 11D. Hum. Genet. 97, 256–259 ( 1996).
Xu, X. et al. Centrosome amplification and a defective G2-M checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389–396 ( 1999).
Crook, T., Crossland, S., Crompton, M.R., Osin, P. & Gusterson, B.A. p53 mutations in BRCA1-associated familial breast cancer. Lancet 350, 638– 639 (1997).
Crook, T. et al. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene 17, 1681–1689 (1998).
Morgan, S.E. & Kastan, M.B. p53 and ATM: cell cycle, cell death, and cancer. Adv. Cancer Res. 71, 1– 25 (1997).
Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215– 221 (1992).
Prolla, T.A. DNA mismatch repair and cancer. Curr. Opin. Cell Biol. 10, 311–316 (1998).
Kinzler, K.W. & Vogelstein, B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386, 761–763 (1997).
Cressman, V.L. et al. Mammary tumor formation in p53- and BRCA1-deficient mice. Cell Growth Differ. 10, 1– 10 (1999).
Tseng, S.L. et al. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer. Genes Chromosomes Cancer 20, 377–382 ( 1997).
Yang, X., Li, C., Xu, X. & Deng, C. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad. Sci. USA 95, 3667 –3672 (1998).
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. & Leder, P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911–921 (1996).
Deng, C.X. et al. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8, 3045 –3057 (1994).
Gu, H., Marth, J.D., Orban, P.C., Mossmann, H. & Rajewsky, K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265, 103–106 (1994).
Robinson, G.W. & Hennighausen, L. Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 124, 2701– 2708 (1997).
Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl Acad. Sci. USA 93, 5860–5865 (1996).
Johnson, P., Gray, D., Mowat, M. & Benchimol, S. Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells. Mol. Cell. Biol. 11, 1– 11 (1991).
Acknowledgements
We thank H. Gu for pMC1-Cre and L. Donehower for Trp53–/– mice; J. Gotay and L. Garrett for technical assistance; D.E. Green for assistance with morphological characterization of mammary gland tumours; and S.G. Brodie, G. Robinson, F. Scotts and H. Varmus for critically reading the manuscript. K.U.W. was supported through funding by the DFG (Wa 1119/1-1).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xu, X., Wagner, KU., Larson, D. et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22, 37–43 (1999). https://doi.org/10.1038/8743
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/8743
This article is cited by
-
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy
Nature Communications (2022)
-
Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage
Oncogenesis (2022)
-
PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Breast Cancer Research (2021)
-
Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
npj Breast Cancer (2021)
-
Dual recombinase action in the normal and neoplastic mammary gland epithelium
Scientific Reports (2021)